Seeking Relief From “Marathon” Migraines? (NAPSA)—“Nothing lasts forever,” the saying goes. However,if you are one of nearly 30 million Americans whosuffer from debili- tating migraine headaches, this might not seem true. That’s because migraines can persist for more than a full day. For manysufferers, they last as long as 72 hours. During these attacks, common symptomsinclude severe, throbbing pain on oneor both sides of the head, nausea, and sensitivity to light and sound. The pain and related symptoms can leave sufferers unable to work or even get out of bed. While there are migraine treat- ments available, a study found that seven out of 10 patients are still not satisfied with their current migraine therapy because the pain relief does notlast. “Migraine attacks can severely disrupt a person’s life,” said Dr. Roger Cady, the director of the Headache Care Center and the Primary Care Network in Spring- field, Mo. “Sufferers need to find relief from the pain and symptoms of a migraine and keep it from returning.” Cady says there is a new option for treating acute migraines called Frova”™(frovatriptan succinate). Unlike other treatments, the active ingredients in Frova remain in the blood for 26 hours, at least 20 hours longer than any other drugofthis type. “Many of the patients I have treated with Frova found relief from migraine symptoms with only one dose of the medication,” said Cady. “The fact that Frova remains in the bloodstream for longer than similar drugs may help migraine patients find effective treatment. I believe it repre- A new option for treating migraines may provide relief to an estimated 30 million sufferers. sents an exciting new option for both physicians and patients, especially those with long-lasting migraines.” Frova is in a class of drugs called triptans. It is unclear exactly how these drugs work to treat migraine pain, but they play a role in relieving the inflammation of the blood vessels in the brain and scalp. This may reduce the pressure on pain-sensitive areas and alter the way the brain perceives pain. If you or someone you know suffers from migraines and is not satisfied with current migraine treatments, contact a physician to discuss new treatment options. Most side effects reported by patients taking Frova were described as mild or moderate and temporary. They included dizzi- ness, fatigue, paresthesia (a burning or prickling sensation), flushing, dry mouth, hot or cold sensations and chest pain. For more information about Frova, log onto www.elan.com or call 1-888-638-7605.
